tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PolyPid Reports Strong Phase 3 Results and Financial Update
PremiumCompany AnnouncementsPolyPid Reports Strong Phase 3 Results and Financial Update
1M ago
PolyPid Releases Mid-2025 Financial Update
Premium
Company Announcements
PolyPid Releases Mid-2025 Financial Update
1M ago
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
Premium
Ratings
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
1M ago
PolyPid appoints Tweezer-Zaks as Chief Medical Officer
PremiumThe FlyPolyPid appoints Tweezer-Zaks as Chief Medical Officer
2M ago
PYPD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PYPD Upcoming Earnings Report: What to Expect?
2M ago
PolyPid files to sell  7.63M ordinary shares for holders
Premium
The Fly
PolyPid files to sell 7.63M ordinary shares for holders
2M ago
PolyPid price target lowered to $9 from $12 at Roth Capital
PremiumThe FlyPolyPid price target lowered to $9 from $12 at Roth Capital
3M ago
PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
Premium
Company Announcements
PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
3M ago
PolyPid price target lowered to $14 from $16 at Citizens JMP
Premium
The Fly
PolyPid price target lowered to $14 from $16 at Citizens JMP
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100